MY ACCOUNT | NEWSLETTER |

Good clinical outcomes in young dogs with tibial tuberosity avulsion fracture repairs


Objective: To evaluate outcomes of tibial tuberosity avulsion fractures (TTAF) in dogs with implants left in situ past skeletal maturity and to compare clinical outcomes with published outcomes in dogs whose implants were removed four to six weeks postoperatively.

Animals: 47 client-owned dogs.

Procedures: In this retrospective study, 47 dogs had surgery to correct a TTAF before 10 months of age and had the implants left in situ past skeletal maturity. Of these, 42 were followed for a median of 36 months postoperatively. Short- and long-term complications were recorded and compared with historically published data in which the implants were removed within six weeks of surgery.

Results: 14% or 6 of 42 dogs experienced minor long-term complications including stiffness and lameness. Three of 47 or 6% experienced major short-term complications and 14% or 6 of 24 dogs experienced major long-term complications. There was no difference in long-term outcomes when compared with results of historical reports in which implants were removed four to six weeks postoperatively. Client satisfaction was high, with 93% or 38 of 41 grading outcomes as excellent and 95% or 39 of 41 stating they would have surgery performed again.

Clinical relevance: Immature dogs with surgically repaired TTAFs have favorable long-term outcomes when the implants were left in situ past skeletal maturity. Dogs with TTAF repairs may not need implant removal unless it becomes clinically necessary. Avoiding a second procedure will decrease patient morbidity, recovery time and cost.

Zachary A. Miller, Sady Y. Cabrera, David Mason and Philip H. Kass. "Good clinical outcomes achieved in young dogs with tibial tuberosity avulsion fracture repairs when implants were left in situ past skeletal maturity." JAVMA. Volume 260: Issue 15: 28 September 2022. DOI: https://doi.org/10.2460/javma.22.07.0336

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Experimental Vaccine Protection Against Feline Immunodeficiency Virus

Like0
Dislike0

In vitro force mapping of normal canine humeroradial and humeroulnar joints

Like0
Dislike0

Prevalence of antibodies to Haemophilus pleuropneumoniae in Iowa swine

Like0
Dislike0

Breakthrough takes big step toward safe, reversible male contraception

Like0
Dislike0

IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top